These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9797597)

  • 1. Side to side comparison of topical treatment in atopic dermatitis.
    Ainley-Walker PF; Patel L; David TJ
    Arch Dis Child; 1998 Aug; 79(2):149-52. PubMed ID: 9797597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
    Wananukul S; Chatproedprai S; Chunharas A; Limpongsanuruk W; Singalavanija S; Nitiyarom R; Wisuthsarewong W
    J Med Assoc Thai; 2013 Sep; 96(9):1135-42. PubMed ID: 24163988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
    BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children.
    Lucky AW; Leach AD; Laskarzewski P; Wenck H
    Pediatr Dermatol; 1997; 14(4):321-4. PubMed ID: 9263319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
    Mailhol C; Lauwers-Cances V; Rancé F; Paul C; Giordano-Labadie F
    Allergy; 2009 May; 64(5):801-6. PubMed ID: 19183418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal function following topical steroid treatment in children with atopic dermatitis.
    Patel L; Clayton PE; Addison GM; Price DA; David TJ
    Br J Dermatol; 1995 Jun; 132(6):950-5. PubMed ID: 7662574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.
    Furue M; Terao H; Rikihisa W; Urabe K; Kinukawa N; Nose Y; Koga T
    Br J Dermatol; 2003 Jan; 148(1):128-33. PubMed ID: 12534606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednicarbate emollient cream 0.1% in pediatric patients with atopic dermatitis.
    Moshang T
    Cutis; 2001 Jul; 68(1):63-9. PubMed ID: 11480151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema.
    Thomas KS; Armstrong S; Avery A; Po AL; O'Neill C; Young S; Williams HC
    BMJ; 2002 Mar; 324(7340):768. PubMed ID: 11923161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution.
    Wolkerstorfer A; Visser RL; De Waard van der Spek FB; Mulder PG; Oranje AP
    Br J Dermatol; 2000 Nov; 143(5):999-1004. PubMed ID: 11069509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study.
    Grimalt R; Mengeaud V; Cambazard F;
    Dermatology; 2007; 214(1):61-7. PubMed ID: 17191050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of conventional therapy in atopic dermatitis.
    Wollenberg A; Schnopp C
    Immunol Allergy Clin North Am; 2010 Aug; 30(3):351-68. PubMed ID: 20670818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of atopic dermatitis].
    Teillac-Hamel D; de Prost Y
    Arch Pediatr; 1995 Sep; 2(9):883-5. PubMed ID: 7581787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triderm in the treatment of atopic dermatitis].
    Kaliuzhnaia DD
    Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical steroid therapy of atopic skin diseases.
    Thiers BH
    Allergy Proc; 1989; 10(6):413-6. PubMed ID: 2697633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.